ACTIVE

Calluna Pharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-32,5 k €

+18.3% YoY

Gross margin

-31,2 k €

-3.2% YoY

Equity

70,3 k €

-31.6% YoY

What does Calluna Pharma do?

Calluna Pharma is a Private limited company incorporated in 2004. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Hoogstraten.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0866.397.070

Incorporation

16/07/2004

Legal form

Private limited company

Registered office

Witherenweg 54
2322 Hoogstraten · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

21100Manufacture of basic pharmaceutical products· main 21100Manufacture of basic pharmaceutical products 24410Precious metals production 21201Manufacture of pharmaceutical preparations 21201Manufacture of pharmaceutical preparations 24421Aluminium production+12

Signals

Solid equityLow riskGood liquidity

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	-31,2 k €	-3.2%	-30,2 k €	-242%	21,3 k €	-58.6%	51,4 k €	-8.1%	56 k €	+115%	26 k €	-67.9%	81,1 k €	+474%	14,1 k €	-89.5%	134,8 k €	-9.0%	148,1 k €	+11.6%	132,7 k €	+1.5%	130,8 k €	-18.6%	160,6 k €	-55.0%	357,2 k €	+30.1%	274,5 k €	-19.0%	338,9 k €	-11.2%	381,6 k €	+130%	165,5 k €	+18240%	-912,6 €	-4.0%	-877,5 €
EBITDA	-32,6 k €	+18.6%	-40 k €	-294%	20,6 k €	-59.2%	50,5 k €	-7.9%	54,9 k €	+124%	24,5 k €	-69.4%	79,8 k €	+499%	13,3 k €	-90.0%	132,7 k €	-8.4%	144,9 k €	+23.0%	117,8 k €	-9.5%	130,1 k €	-18.3%	159,4 k €	-55.3%	356,2 k €	+31.0%	271,9 k €	-18.3%	332,8 k €	-12.2%	378,9 k €	+134%	162 k €	+10919%	-1,5 k €	-18.6%	-1,3 k €
Operating result	-32,6 k €	+18.6%	-40 k €	-294%	20,6 k €	-59.2%	50,5 k €	-7.9%	54,9 k €	+124%	24,5 k €	-69.4%	79,8 k €	+499%	13,3 k €	-90.0%	132,7 k €	-8.4%	144,9 k €	+28.5%	112,7 k €	-10.6%	126 k €	-18.6%	154,9 k €	-55.7%	350 k €	+36.0%	257,4 k €	-18.9%	317,5 k €	-13.1%	365,2 k €	+147%	148,1 k €	+2644%	-5,8 k €	-6.0%	-5,5 k €
Net result	-32,5 k €	+18.3%	-39,7 k €	-356%	15,5 k €	-58.6%	37,5 k €	-8.6%	41 k €	+124%	18,3 k €	-67.5%	56,3 k €	+491%	9,5 k €	-89.1%	87,4 k €	-9.6%	96,6 k €	+27.3%	75,9 k €	-9.7%	84 k €	+807%	9,3 k €	-96.2%	240,9 k €	-7.5%	260,4 k €	+24.0%	210,1 k €	-11.5%	237,3 k €	+147%	96 k €	+1749%	-5,8 k €	-5.8%	-5,5 k €
Balance sheet
Equity	70,3 k €	-31.6%	102,7 k €	-27.9%	142,4 k €	+12.2%	126,9 k €	+41.9%	89,5 k €	+84.4%	48,5 k €	+60.4%	30,2 k €	+26.1%	24 k €	-79.1%	114,5 k €	+323%	27,1 k €	-86.4%	199,4 k €	+61.4%	123,5 k €	+213%	39,5 k €	-52.2%	82,6 k €	+97.8%	41,8 k €	-82.6%	239,7 k €	+165%	90,5 k €	-1.3%	91,7 k €	+2722%	3,3 k €	+198%	-3,3 k €
Total assets	73,2 k €	-30.7%	105,6 k €	-32.4%	156,3 k €	+13.7%	137,6 k €	+47.6%	93,2 k €	+69.8%	54,9 k €	-36.2%	86 k €	-42.7%	150,1 k €	+10.6%	135,8 k €	+9.8%	123,6 k €	-45.6%	227,1 k €	+66.5%	136,3 k €	+44.6%	94,3 k €	-80.4%	482,1 k €	+52.3%	316,5 k €	-23.2%	411,9 k €	-4.1%	429,6 k €	+146%	174,7 k €	+602%	24,9 k €	+57.5%	15,8 k €
Cash	66 k €	-33.4%	99 k €	-36.7%	156,3 k €	+179%	56,1 k €	-36.6%	88,4 k €	+69.7%	52,1 k €	-36.0%	81,4 k €	-44.1%	145,5 k €	+38.9%	104,7 k €	-14.4%	122,4 k €	-35.6%	190 k €	+131%	82,2 k €	-5.8%	87,3 k €	-54.6%	192,3 k €	+61.5%	119,1 k €	-57.2%	278 k €	-4.0%	289,7 k €	+560%	43,9 k €	+232%	13,2 k €	+9439%	138,6 €
Debts	3 k €	+1.8%	2,9 k €	-79.0%	13,9 k €	+30.6%	10,6 k €	+186%	3,7 k €	-41.7%	6,4 k €	-88.6%	55,7 k €	-55.8%	126,1 k €	+492%	21,3 k €	-77.9%	96,5 k €	+249%	27,7 k €	+116%	12,8 k €	-76.6%	54,8 k €	-86.3%	399,5 k €	+45.4%	274,7 k €	+60.1%	171,6 k €	-49.4%	339 k €	+312%	82,2 k €	+280%	21,6 k €	+13.1%	19,1 k €
Other
Workforce	–		0,0 ETP		0,0 ETP		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 10 ended

Active mandates

KEMIA

Director · 0555.976.383

Represented by Jan Embrechts

Active

Ended mandates

KEMIA

Director · since 31 mars 2022 · 0555.976.383

Ended

KEMIA

Director · since 01 janvier 2018 · 0555.976.383

Represented by Jan EMBRECHTS

Ended

KEMIA

Director · since 01 janvier 2018 · 0555.976.383

Ended

KEMIA

Manager · since 01 janvier 2018 · 0555.976.383

Represented by Jan Embrechts

Ended

At this address

Other companies at this address

Company	CBE no.
KEMIA● Active	0555.976.383

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2026	24/06/2025	18/06/2024	03/07/2023	30/06/2022	07/06/2021
General meeting	27/05/2026	28/05/2025	29/05/2024	21/06/2023	25/05/2022	26/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	27/05/2026	22/06/2026	Dutch	PDF
Abridged model	31/12/2024	28/05/2025	24/06/2025	Dutch	PDF
Abridged model	31/12/2023	29/05/2024	18/06/2024	Dutch	PDF
Abridged model	31/12/2022	21/06/2023	03/07/2023	Dutch	PDF
Abridged model	31/12/2021	25/05/2022	30/06/2022	Dutch	PDF
Abridged model	31/12/2020	26/05/2021	07/06/2021	Dutch	PDF
Abridged model	31/12/2019	27/05/2020	24/06/2020	Dutch	PDF
Abridged model	31/12/2018	29/05/2019	11/06/2019	Dutch	PDF
Abridged model	31/12/2017	30/05/2018	22/06/2018	Dutch	PDF
Abridged model	31/12/2016	31/05/2017	06/06/2017	Dutch	PDF
Abridged model	31/12/2015	25/05/2016	26/05/2016	Dutch	PDF
Abridged model	31/12/2014	27/05/2015	18/06/2015	Dutch	PDF
Abridged model	31/12/2013	28/05/2014	16/07/2014	Dutch	PDF
Abridged model	31/12/2012	29/05/2013	15/07/2013	Dutch	PDF
Abridged model	31/12/2011	30/05/2012	30/05/2012	Dutch	PDF
Abridged model	31/12/2010	25/05/2011	01/06/2011	Dutch	PDF
Abridged model	31/12/2009	26/05/2010	28/05/2010	Dutch	PDF
Abridged model	31/12/2008	27/05/2009	16/06/2009	Dutch	PDF
Abridged model	31/12/2007	28/05/2008	04/06/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	03/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 10 ended

Active mandates

KEMIA

Director · 0555.976.383

Represented by Jan Embrechts

Active

Ended mandates

KEMIA

Director · since 31 mars 2022 · 0555.976.383

Ended

KEMIA

Director · since 01 janvier 2018 · 0555.976.383

Represented by Jan EMBRECHTS

Ended

KEMIA

Director · since 01 janvier 2018 · 0555.976.383

Ended

KEMIA

Manager · since 01 janvier 2018 · 0555.976.383

Represented by Jan Embrechts

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office23/01/2025
Zetel (zetelverplaatsing)
PDF
Mandates12/04/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/02/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/01/2017
ONTSLAGEN - BENOEMINGEN
PDF
Registered office04/04/2008
MAATSCHAPPELIJKE ZETEL
PDF
Other27/07/2004
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-32,5 k €↑
2024
Annual accounts 2024-39,7 k €↓
2023
Annual accounts 202315,5 k €↓
2022
Annual accounts 202237,5 k €↓
2021
Annual accounts 202141 k €↑
2020
Annual accounts 202018,3 k €↓
2019
Annual accounts 201956,3 k €↑
2018
Annual accounts 20189,5 k €↓
2017
Annual accounts 201787,4 k €↓
2016
Annual accounts 201696,6 k €↑
2015
Annual accounts 201575,9 k €↓
2014
Annual accounts 201484 k €↑
2013
Annual accounts 20139,3 k €↓
2012
Annual accounts 2012240,9 k €↓
2011
Annual accounts 2011260,4 k €↑
2010
Annual accounts 2010210,1 k €↓
2009
Annual accounts 2009237,3 k €↑
2008
Annual accounts 200896 k €↑
2007
Annual accounts 2007-5,8 k €↓
2006
Annual accounts 2006-5,5 k €
16/07/2004
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Calluna Pharma

Overview

What does Calluna Pharma do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline